Show simple item record

dc.contributor.authorChew, Derek Peng
dc.contributor.authorLincoff, A Michael
dc.contributor.authorGurm, Hitinder
dc.contributor.authorWolski, Katherine
dc.contributor.authorCohen, David J
dc.contributor.authorHenry, Tim
dc.contributor.authorFeit, Frederick
dc.contributor.authorTopol, Eric J
dc.date.accessioned2010-07-27T06:03:28Z
dc.date.available2010-07-27T06:03:28Z
dc.date.issued2005en_US
dc.identifier.citationChew, D.P., Lincoff, A.M., Gurm, H., Wolski, K., Cohen, D.J., Henry, T., Feit, F., & Topol, E.J., 2005. Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial). American Journal of Cardiology, 95(5), 581-585.en
dc.identifier.issn0002-9149en_US
dc.identifier.urihttp://hdl.handle.net/2328/9998
dc.titleBivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (A subanalysis of the REPLACE-2 trial)en_US
dc.typeArticleen_US
dc.identifier.rmid2005100965en_US
dc.identifier.doihttps://doi.org/10.1016/j.amjcard.2004.11.003en
dc.subject.forgroup1102 Cardiovascular Medicine and Haematologyen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record